Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts

American Journal of Kidney Diseases

Volumn 38, Issue 6, 2001, Pages 1240-1244

  Gradzki, Robert ^a   Dhingra, Rajnish K ^a   Port, Friedrich K ^a   Roys, Erik ^a   Weitzel, William F ^a   Messana, Joseph M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Access survival; Angiotensin converting enzyme (ACE) inhibition; Hemodialysis (HD); Vascular access

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POLITEF;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIALYSIS; DRUG USE; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR ACCESS;

EID: 0035719891     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.29220     Document Type: Article

References (21)

1. Excerpts from the USRDS 1999 annual data report
2. Hemodialysis access failure: A call to action
3. Hemodialysis vascular access morbidity
4. Canadian hemodialysis morbidity study
5. Vascular access: Concepts for the 1990s
6. Hemodialysis vascular access morbidity in the United States
7. Predictors of type of vascular access in hemodialysis patients
8. Use of standardized ratios to examine variability in hemodialysis vascular access across facilities
9. Vascular access survival among incident hemodialysis patients in the United Stales
10. National surveillance of dialysis-associated diseases in the United States, 1997
11. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment
12. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
13. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
14. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist
15. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries
16. ACE-inhibitors prolong PTFE graft survival in hemodialysis patients
17. Angiotensin II inhibition prevents the occlusion of arterio-venous fistula in hemodialysis patients: A case-control study
18. Pharmacological strategies to prevent restenosis: Lessons learned from blockade of the renin-angiotensin system
19. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multi-center, randomized, double-blind placebo-controlled trial
20. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double blind, placebo controlled trial of clizapril
21. Changes in venous histology in chronic hemodialysis patients